| Study highlights 'substantial need' to provide DAA therapy to all patients with HCV |
| Saturday, January 07, 2023 01:37 PM |
| Direct-acting antiviral treatment significantly lowered the risk for mortality and liver and non-liver outcomes in patients with chronic hepatitis C virus infection, regardless of disease stage, researchers reported. Read more. |
Daily News
- A drill bit went down his throat and it looked like he might need surgery; then they tried something else
- CDC asks states and cities to keep flu surveillance at peak levels because of bird flu threat
- Department of Labor announces final rule updating the Hazard Communication Standard to better protect workers, first responders
- Dental Group of Amarillo notifying patients of possible data breach
- Ouch! What’s wrong with my hands?
Our Sponsors
